Show
Sort by
-
- Journal Article
- A1
- open access
Promising tools to facilitate the implementation of TDM of biologics in clinical practice
-
- Journal Article
- A1
- open access
Effect of risankizumab on patient-reported outcomes in moderate to severe psoriasis : the UltIMMa-1 and UltIMMa-2 randomized clinical trials
-
- Journal Article
- A1
- open access
Response to IL‐17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein‐coding and untranslated regions of the IL‐17A gene : results from a multicentre study of four European psoriasis cohorts
-
Targeting the IL-23/IL-17 pathway in psoriasis : the search for the good, the bad and the ugly
-
Quality of life and patient benefit following transition from methotrexate to ustekinumab in psoriasis
-
European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies : 2015 update